Top 3 Health Care Stocks That Could Blast Off In December
Top 3 Health Care Stocks That Could Blast Off In December
12月份可能大涨的三大医疗保健股票
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
医疗保健板块中最超卖的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指标是一种动量指标，它比较了股票在价格上涨时的强度与在价格下跌时的强度。与股票的价格走势进行比较，可以给交易者更好的了解股票短期内表现的良好程度。当RSI低于30时，资产通常被认为是超卖的，根据Benzinga Pro的数据。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行业板块最近的主要超卖股票列表，RSI接近或低于30。
Revolution Medicines Inc (NASDAQ:RVMD)
Revolution Medicines公司（纳斯达克:RVMD）
- On Dec. 3, Revolution Medicines priced its upsized $750 million public offering of 14,130,436 common stock at $46/share and pre-funded warrants. The company's stock fell around 17% over the past five days and has a 52-week low of $23.38.
- RSI Value: 27.88
- RVMD Price Action: Shares of Inter fell 6.9% to close at $48.23 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest RVMD news.
- Revolution Medicines在12月3日定价其扩大规模的75000万美元公开发行14,130,436股普通股，价格为46美元/股，附带提前融资认股权证。该公司股价在过去五天下跌了约17%，52周最低价为23.38美元。
- RSI数值: 27.88
- RVMD股价走势: Inter股价周二下跌6.9%，收于48.23美元。
- Benzinga Pro的实时新闻提醒了最新的RVMD资讯。
Elanco Animal Health Inc (NYSE:ELAN)
elanco animal health股票公司（纽交所：ELAN）
- On Dec. 2, Leerink Partners analyst Daniel Clark initiated coverage on Elanco Animal Health with a Market Perform rating and announced a price target of $14. The company's stock fell around 7% over the past five days and has a 52-week low of $11.40.
- RSI Value: 27.85
- ELAN Price Action: Shares of Elanco Animal Health fell 7.4% to close at $12.48 on Tuesday.
- Benzinga Pro's charting tool helped identify the trend in ELAN stock.
- 12月2日，Leerink Partners分析师Daniel Clark对Elanco Animal Health进行了覆盖，并给出了市场表现评级，并宣布了14美元的价格目标。该公司股票在过去五天下跌了约7%，52周最低价为11.40美元。
- 相对强弱指标数值：27.85
- ELAN股票走势：Elanco Animal Health股票周二下跌7.4%，收于12.48美元。
- Benzinga Pro的图表工具帮助识别了ELAN股票的趋势。
Sotera Health Co (NASDAQ:SHC)
Sotera Health Co（纳斯达克：SHC）
- On Nov. 5, Sotera Health reported quarterly earnings of 17 cents per share which missed the analyst consensus estimate of 18 cents per share. The company reported quarterly sales of $285.468 million which beat the analyst consensus estimate of $278.585 million. "I am pleased we achieved both top- and bottom-line growth for the third-quarter," said Chairman and Chief Executive Officer Michael B. Petras, Jr. "Our performance was largely in line with expectations, with an additional benefit at Nordion tied to the timing of cobalt-60 shipments. With most of the year behind us, we are reaffirming the 2024 revenue and EBITDA outlook ranges previously provided." The company's stock fell around 19% over the past month and has a 52-week low of $10.71.
- RSI Value: 29.58
- SHC Price Action: Shares of Sotera Health fell 3.2% to close at $12.83 on Tuesday.
- Benzinga Pro's signals feature notified of a potential breakout in SHC shares.
- Sotera Health在11月5日报告每股17美分的季度收入，低于分析师一致估计的每股18美分。该公司季度销售额为28546.8万美元，超过分析师一致估计的27858.5万美元。“我很高兴我们在第三季度取得了营收和净利润的增长。”董事长兼首席执行官Michael B. Petras, Jr.说。“我们的表现基本符合预期，而Nordion部门因钴60出货时间的特殊情况有额外收益。随着大部分年度已经过去，我们再次确认之前提供的2024年营收和EBITDA预期范围。”该公司股票在过去一个月下跌约19%，52周最低价为10.71美元。
- RSI值：29.58
- SHC股价走势：Sotera Health股价周二下跌3.2%，收于12.83美元。
- Benzinga Pro的信号特征通知了Sotera Health股票SHC可能出现突破。
Read More:
阅读更多：
- Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons'
- 吉姆·克莱默更喜欢联邦快递，而不是这家曾经“搞砸了很多个假期季节”的快递巨头。